We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stem Cell Therapeutics Announces Completion of Enrollment in Key Modified REGENESIS Phase IIb Stroke Trial

News   Apr 01, 2010

 
Stem Cell Therapeutics Announces Completion of Enrollment in Key Modified REGENESIS Phase IIb Stroke Trial
 
 
 

RELATED ARTICLES

Clinical Prospects for Stem Cells Begin to Emerge

News

There is now a critical mass of experts in this field and things are moving much faster, Stanford scientists say.

READ MORE

Human Skeletal Stem Cells Isolated for the First Time

News

This is the first time that skeletal stem cells, which had been observed in rodents, have been identified in humans.

READ MORE

Snooker in the Living Cell

News

The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE